Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes-Reference-Cited by-同舟云学术

Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes

Published:2017-10 Issue:10 Volume:116 Page:774-781
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Huang Ying-Jung,Coustan-Smith Elaine,Kao Hsiao-Wen,Liu Hsi-Che,Chen Shih-Hsiang,Hsiao Chih-Cheng,Yang Chao-Ping,Jaing Tang-Her,Yeh Ting-Chi,Kuo Ming-Chung,Lai Chang-Liang,Chang Chia-Hui,Campana Dario,Liang Der-Cherng,Shih Lee-Yung

Funder

Mackay Memorial Hospital

Terry Fox Foundation

Chang Gung Memorial Hospital

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Detection of minimal residual disease in acute leukemia by flow cytometry;Campana;Cytometry,1999

2. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukemia: a prospective study;Pui;Lancet Oncol,2015

3. Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial